Search clinical trials for: CKD-386(4) F1
Total 160 results
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknown
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension | DyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalSeoul National University Bundang HospitalCompletedHealthyKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension | DyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedClinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy VolunteersChronic Renal FailureKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknown
-
Chong Kun Dang PharmaceuticalUnknownHypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedGERDKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalNot yet recruitingCardiovascular DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalNot yet recruitingCardiovascular DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType 2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedGERDKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType II DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalRecruiting
-
Chong Kun Dang PharmaceuticalCompletedEndocrine, Nutritional and Metabolic DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEndocrine, Nutritional and Metabolic DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEndocrine, Nutritional and Metabolic DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedCardiovascular DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedChronic Hepatitis bKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownChronic Hepatitis bKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedCardiovascular DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownCardiovascular DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedCardiovascular DiseasesKorea, Republic of
-
Cardiff UniversityPodiatry Department, Cardiff & Vale University Health Board; School of Health... and other collaboratorsUnknownChronic Kidney DiseaseUnited Kingdom
-
Chong Kun Dang PharmaceuticalCompletedHealthy Male VolunteerKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedGERDKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownCardiovascular DiseasesKorea, Republic of
-
CK Regeon Inc.Completed
-
CytokineticsCompletedChronic Heart Failure | Pharmacokinetics | Left Ventricular Systolic Dysfunction | Left Ventricular Ejection Fraction | Modified Release Oral Formulation | History of Chronic Heart Failure | EchocardiogramUnited States, Canada, Italy, Netherlands, United Kingdom, Belgium, Czechia, Australia, Hungary, Poland, Bulgaria, Lithuania, Germany
-
G1 Therapeutics, Inc.CompletedHealthy VolunteersNetherlands
-
G1 Therapeutics, Inc.CompletedHealthy VolunteersNetherlands
-
Tianjin Medical University Cancer Institute and...Not yet recruitingAdvanced HR+ HER2 Negative Breast Carcinoma
-
Boehringer IngelheimCompleted